Nogo-C contributes to HCC tumorigenesis via suppressing cell growth and its interactome analysis with comparative

Xing Liu1, Shu-Jian Cui2, Shi-Jun Zhu3

  • 1State Key Laboratory of Genetic Engineering, Fudan University Shanghai, China ; National Engineering Center for Biochip at Shanghai Shanghai, China.

Abstract

Insights

Nogo-C acts as a tumor suppressor in hepatocellular carcinoma (HCC), with its decreased expression linked to worse prognosis. Overexpressing Nogo-C inhibits HCC cell growth, revealing new therapeutic avenues.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Neurite outgrowth inhibitor proteins (Nogos) are a family with conserved RHD domains.
  • Nogo-B is implicated in liver cirrhosis, while Nogo-C has been less studied.
  • Hepatocellular carcinoma (HCC) is a major global health concern.

Purpose of the Study:

  • To investigate the role and mechanism of Nogo-C in Hepatocellular Carcinoma (HCC).
  • To determine if Nogo-C functions as a tumor suppressor or oncogene in HCC.
  • To identify proteins interacting with Nogo-C in HCC.

Main Methods:

  • Quantitative RT-PCR to measure Nogo-C mRNA expression in HCC tissues.
  • Cell proliferation and colony formation assays to assess Nogo-C function.
  • Affinity purification coupled with mass spectrometry to identify Nogo-C binding proteins.

Main Results:

  • Nogo-C mRNA expression was significantly downregulated in HCC specimens, correlating with larger tumor size and poorer prognosis.
  • Overexpression of Nogo-C inhibited HCC cell growth in vitro.
  • B-raf and Nogo-B were identified as Nogo-C interacting proteins.

Conclusions:

  • Nogo-C acts as a tumor suppressor gene in HCC.
  • B-raf is a novel interacting protein with Nogo-C.
  • These findings offer new insights into the Nogo family's mechanism in cancer.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K